CIK 0001862150 · <br>Emerging growth company
Cingulate Inc.
Sign in to watch- Ticker
- CING
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863825535
- Phone
- (913) 942-2300
- Business address
- 1901 W. 47TH PLACE, KANSAS CITY, KS, 66205
- Former names
- Cingulate Inc.
Securities
- CING Common Stock Nasdaq
- CINGW Warrants Nasdaq
- DRS Other Draft Registration Statement
- 4 Open-market buy EVP and COO bought 1,111 shares at $0.90 ($1,000)
- 4 Open-market buy Corporate Controller bought 5,017 shares at an average $0.98 ($4,916)
- 4 Open-market buy EVP, GC and Secretary bought 3,575 shares at $0.84 ($3,003)
- 4 Open-market buy Director bought 85,000 shares at $0.88 ($74,851)
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Material agreement · Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change
- 4 Open-market sale Director sold 17,532 shares at $1.27 ($22,208)
- 8-K Event Regulation FD disclosure
- 4 Open-market buy Corporate Controller bought 3,500 shares at $1.50 ($5,250)
- 4 Open-market buy Director bought 74,500 shares at $1.52 ($113,225)
- 4 Open-market buy EVP and COO bought 636 shares at $1.57 ($999)
- 4 Derivatives Options or other derivatives
- 424B3 Offering Prospectus
- 3 Insider Initial Statement of Ownership
- 10-Q Report Quarterly Report
Page 19 of 25 · 494 filings